APOQUEL FCT 5.4MG TABLET, a prominent offering from , is a targeted veterinary medicine for dogs. This tablet is specially formulated to manage the itching associated with allergic dermatitis, including atopy, in dogs older than 12 months. It contains the active ingredient Oclacitinib, a synthetic Janus Kinase (JAK) inhibitor, providing a novel approach to allergy management in dogs.

Ingredients:

Oclacitinib Maleate: The principal component, Oclacitinib, effectively controls itch and inflammation through the inhibition of JAK1 and JAK3 enzymes, crucial in allergic reactions.